Nominal Dose Closed Cabinet X-Ray Detects Items Concealed in Body Cavities
YOUNGSVILLE, LA / ACCESSWIRE / April 11, 2016 / RedHawk Holdings Corp. (IDNG) ("RedHawk" or the "Company") announced today that it has acquired the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System ("Centri"), a unique, nominal dose transmission full body x-ray scanner capable of finding weapons, drugs and other metallic and non-metallic contraband concealed on and within the human body. The Company acquired these exclusive rights from Basic Technologies, Inc. ("BTI") who holds the exclusive worldwide license to manufacture and sell Centri.
Centri was successfully used as an important security tool at the Sochi Winter Olympic Games to search attendees and is currently widely used within Russia’s transportation sector. While entering the transportation sector is a long-range company objective, RedHawk said it will focus its initial marketing strategy on state and local correctional facilities. The Company expects manufacturing and assembly of the first Centri unit to commence on or before June 30, 2016.
Centri is a nominal dose, closed cabinet, transmission full body x-ray scanner safe and effective for general check point security. Centri produces a near medical quality image, revealing all items a person is either carrying, has ingested or has inserted within a body cavity or hidden in clothing. By scanning inmates, guards and visitors, correction facilities can quickly and safely detect weapons, drugs and other contraband on or with a person. Centri is capable of finding drugs, metallic and non-metallic contraband concealed within clothing, prosthetics and body cavities - something existing scanners typically used in airports and government buildings are not capable of detecting. The Company said it believes Centri will be useful in keeping drugs, weapons and other contraband from being smuggled via body cavities and endangering both inmates and correctional officers alike.
Centri’s uniqueness and competitive advantage stems from proprietary x-ray technology, resulting in extremely high resolution with minimal radiation emissions. These features result from its proprietary design and operating systems that enable it to be used on the same person multiple times per day, 365 days a year and still stay well below U.S. government radiation exposure limits. Based upon both its radiation safety record and its design specifications, the U.S. Food and Drug Administration previously granted permission for the lawful import and sale of Centri within the United States.
Centri will be manufactured and marketed through, Centri Security Systems LLC, a limited liability company owned 50% by RedHawk Energy Corp., LLC, a wholly-owned subsidiary of RedHawk, and 50% by BTI. While its initial marketing strategy will focus on state and local correctional systems, the Company said it will also focus marketing efforts on the precious metals, transportation and energy industries.
This release may contain forward-looking statements. Forward-looking statements are all statements other than statements of historical fact. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. The words "anticipate," "may," "can," "plans," "believes," "estimates," "expects," "projects," "targets," "intends," "likely," "will," "should," "to be," "potential" and any similar expressions are intended to identify those assertions as forward-looking statements.
Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties. In evaluating forward-looking statements, you should consider the various factors which may cause actual results to differ materially from any forward-looking statements including those listed in the "Risk Factors" section of our latest 10-K report. Further, the Company may make changes to its business plans that could or will affect its results. Investors are cautioned that the Company will undertake no obligation to update any forward-looking statements.